scPharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	40.81	75.66	46.81	71.06	74.27	71.82
Short-Term Investments	0.28	1.02	30.36	48.55	1.03	33.28
Cash & Short-Term Investments	41.09	76.68	77.17	119.61	75.3	105.1
Cash Growth	5.70%	-0.64%	-35.48%	58.85%	-28.35%	44.71%
Accounts Receivable	19.41	11.72	4.49	-	-	-
Receivables	19.41	11.72	4.49	-	-	-
Inventory	14.57	13.9	8.84	1.23	-	-
Prepaid Expenses	3.65	3.55	2.44	2.28	2.79	2.61
Restricted Cash	-	-	-	0.18	0.18	-
Other Current Assets	-	-	-	-	-	0.12
Total Current Assets	78.73	105.85	92.94	123.31	78.28	107.83
Property, Plant & Equipment	1.22	1.33	1.46	0.62	0.48	0.91
Other Long-Term Assets	0.3	0.34	0.08	0.27	0.28	0.31
Total Assets	80.26	107.52	94.48	124.2	79.04	109.05
Accounts Payable	4.03	3.88	4	1.52	0.54	1.67
Accrued Expenses	14.8	9.73	8.75	5.29	3.99	4.75
Current Portion of Long-Term Debt	-	-	-	-	9.81	2.41
Current Portion of Leases	0.26	0.24	0.18	0.57	0.48	0.46
Current Income Taxes Payable	-	-	-	-	0.01	0.04
Other Current Liabilities	1.34	1.02	0.21	0.04	0.03	-
Total Current Liabilities	20.43	14.88	13.13	7.42	14.85	9.32
Long-Term Debt	51.2	51.35	38.81	36.79	7.35	16.86
Long-Term Leases	0.98	1.1	1.28	0.01	-	0.48
Other Long-Term Liabilities	28.96	26.87	4.03	7.55	0.37	0.22
Total Liabilities	101.57	94.2	57.26	51.76	22.57	26.88
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	382.94	379.81	318.56	298.93	246.17	243.83
Retained Earnings	-404.26	-366.49	-281.35	-226.54	-189.7	-161.66
Comprehensive Income & Other	-	-	-0	0.03	-0	0
Total Common Equity	-21.32	13.32	37.22	72.43	56.47	82.17
Shareholders' Equity	-21.32	13.32	37.22	72.43	56.47	82.17
Total Liabilities & Equity	80.26	107.52	94.48	124.2	79.04	109.05
Total Debt	52.45	52.69	40.27	37.37	17.64	20.21
Net Cash (Debt)	-11.36	23.98	36.9	82.25	57.67	84.89
Net Cash Growth	-	-35.01%	-55.13%	42.62%	-32.07%	64.53%
Net Cash Per Share	-0.22	0.54	0.96	2.90	2.11	3.46
Filing Date Shares Outstanding	53.3	50.28	36.05	35.77	27.37	27.36
Total Common Shares Outstanding	53.29	50.1	35.97	34.26	27.37	27.33
Working Capital	58.3	90.97	79.8	115.89	63.43	98.51
Book Value Per Share	-0.40	0.27	1.03	2.11	2.06	3.01
Tangible Book Value	-21.32	13.32	37.22	72.43	56.47	82.17
Tangible Book Value Per Share	-0.40	0.27	1.03	2.11	2.06	3.01
Machinery	0.13	0.13	0.11	0.15	0.14	0.13
Leasehold Improvements	0.01	0.01	0.01	0.1	0.1	0.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q